Atkore International Group ATKR 深 沪
已收盘 08-01 16:00:00 美东时间
75.92
-1.100
-1.43%
华盛通- 最 高76.11
- 今 开75.98
- 成交量 50.45万股
- 最 低 73.5033
- 昨 收 77.02
- 总市值 25.55亿
- 52周最高 104.305
- 市盈率 静 5.98
- 换手率 1.50%
- 52周最低 49.59
- 委 比 -90.48%
- 总股本 3365.16万
- 历史最高 193.37
- 量 比 1.27
- 振 幅 3.38%
- 历史最低 8.92
- 每 手 1
- 风险率 29.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Atkore declares $0.33 dividend
Atkore (NYSE:ATKR) declares $0.33/share quarterly dividend, in line with previous. Forward yield 1.7% Payable Aug. 29; for shareholders of record Aug. 19; ex-div Aug. 19. See ATKR Dividend Scorecard, ...
07-31 12:27
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
06-11 09:43
美股大行评级 | eToro Group获多家大行首予买入评级，甲骨文获多家机构上调目标价
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139116149842006017.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持PolyPid(PYPD)"买入"评级，目标价从11美元升至13美元</p> <p>• HC Wainwright & Co.：维持Vertical Aerosp
06-10 09:45
Atkore Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Analysts' ratings for Atkore (NYSE:ATKR) over the last quarter vary from bullis...
06-10 03:00
Citigroup Maintains Neutral on Atkore, Raises Price Target to $80
Citigroup analyst Andrew Kaplowitz maintains Atkore (NYSE:ATKR) with a Neutral and raises the price target from $70 to $80.
06-10 02:32
美股大行评级 | 潜在涨幅105.34%！Amylyx Pharmaceuticals获Leerink Partners升目标价至10美元，上调至"跑赢大市"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
05-08 08:45
Keybanc Maintains Overweight on Atkore, Raises Price Target to $80
Keybanc analyst Jeffrey Hammond maintains Atkore (NYSE:ATKR) with a Overweight and raises the price target from $70 to $80.
05-07 23:28
Here are the major earnings before the open tomorrow
Major earnings expected before the bell on Tuesday include: Archer-Daniels-Midland (ADM) Datadog (DDOG) Duke Energy (DUK) Marathon Petroleum (MPC) MPLX (MPLX) Other earnings slated for release before ...
05-06 06:00
Atkore Expects Strong Solid Q2 Performance Despite Flags Impairment Charge, Reaffirms FY25 Outlook
Atkore Inc. (ATKR) expects strong Q2 results, with net sales of $695-$705M, adjusted EPS of $2.01-$2.08, and adjusted EBITDA of $115-$118M. Labor deal and FY25 outlook reiterated. Impairment charge affected quarterly net loss. Stock up 4.46% premarket.
04-23 02:45
